Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis

The current best practice suggests yearly magnetic resonance imaging (MRI) to monitor treatment response in multiple sclerosis (MS) patients. Objective: To evaluate the current practice of clinicians changing MS treatment based on subclinical new MRI lesions alone. Methods: Using MSBase, an international MS patient registry with MRI data, we analysed the probability of treatment change among patients with clinically silent new MRI lesions. Results: A total of 8311 MRI brain scans of 4232 patients were identified. Around 26.9% (336/1247) MRIs with one new T2 lesion were followed by disease-modifying therapy (DMT) change, increasing to 50.2% (129/257) with six new T2 lesions. DMT change was twice as likely with new T1 contrast enhancing compared to new T2 lesions odds ratio (OR): 2.43, 95% confidence interval (CI): 2.00–2.96 vs OR: 1.26 (95% CI: 1.22–1.29). DMT change with new MRI lesions occurred most frequently with ‘injectable’ DMTs. The probability of switching therapy was greater only after high-efficacy therapies became available in 2007 (after, OR: 1.43, 95% CI: 1.28–1.59 vs before, OR: 0.98, 95% CI: 0.520–1.88). Conclusion: MS clinicians rely increasingly on MRI alone in their treatment decisions, utilizing low thresholds (1 new T2 lesion) for optimizing MS therapy. This signals a shift towards no evidence of disease activity (NEDA)-3 since high-efficacy therapies became available.

Ingår i:Multiple sclerosis (Houndmills, Basingstoke, England): SAGE Publications24:12, s. 1569-15771477-09701352-4585

Av författaren/redakt...: Min, M; Spelman, T; Lugaresi, A; Boz, C; Spitaleri, DLA; Pucci, E; visa fler...; Grand'Maison, F; Granella, F; Izquierdo, G; Butzkueven, H; Sanchez-Menoyo, ...; Barnett, M; Girard, M; Trojano, M; Grammond, P; Duquette, P; Sola, P; Alroughani, R; Hupperts, R; Vucic, S; Kalincik, T; Van pesch, V; Lechner-Scott, J; visa färre...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.